NTT Demonstrates Communications Technologies to Aid Those Living With ALS
Digital avatar, verbal and non-verbal solutions enable users to regain freedom of expression TOKYO--(BUSINESS WIRE)--#TechforGood--NTT…
3 years ago
Inventec and Renesas to Jointly Develop Proof-of-Concept for Automotive Gateways
Technology Partnership Accelerates Development of Next-Generation Vehicles Worldwide TAIPEI, Taiwan & TOKYO--(BUSINESS WIRE)--#Automotive--Inventec (TPE:2356), a…
3 years ago
Six-Year Outcomes from Phase 3 CheckMate -227 Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) in the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer
Data from longest reported follow-up for a Phase 3 trial with immunotherapy in metastatic non-small…
3 years ago
Ghana Sovereign Wealth Fund to Invest in Ewoyaa Project
The Minerals Income Investment Fund of Ghana to acquire 6% interest in Ewoyaa for $27.9…
3 years ago
Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK-279, a Highly Selective Oral TYK2 Inhibitor, for the Treatment of Active Psoriatic Arthritis
− Topline Results for TAK-279 Show that a Significantly Greater Proportion of Psoriatic Arthritis Patients…
3 years ago
Vista Gold Corp. Presenting at the 2023 Precious Metals Summit
DENVER--(BUSINESS WIRE)--Vista Gold Corp. (NYSE American and TSX: VGZ) (“Vista†or the “Companyâ€) announced today…
3 years ago
Netcracker Launches Pioneering Solution to Advance Generative AI for the Telecom Industry
Netcracker GenAI Telco Solution Accelerates the Adoption of High-Value Use Cases Across the Telecom Business…
3 years ago
Heartseed Announces the Presentation of HS-001, an Investigational Stem Cell-Derived Therapy for the Treatment of Advanced Heart Failure at the 71st Annual Meeting of the Japanese College of Cardiology
TOKYO--(BUSINESS WIRE)--#HS001--Heartseed (Heartseed Inc.), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure, today…
3 years ago
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
Clinical trials will advance treatment of COVID-19 infection. BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (“SINOVAC†or the…
3 years ago
Calling All Pet Lovers! Starstreet Precinct Takes Your Furry Friends on a Pawsome Adventure
HONG KONG SAR - Media OutReach - 11 September 2023 - Known for its variety…
3 years ago